Care Access acquires trial centre in Brazil to expand DCT capability
With the takeover, underrepresented population in the Latin American region will have access to clinical trials.
South & Central America
Latest in
South & Central America
Dengue fever: the urgent hunt for antivirals and vaccines
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers overcome obstacles to…
By
Resverlogix expands Phase IIb apabetalone trial for Covid-19
Five more study centres in Brazil as well as a third Canadian site in Toronto, Ontario will become operational soon.
CureVac doses first subject in Phase I influenza vaccine trial
Set to be carried out in Panama, the trial is anticipated to enrol up to 240 healthy subjects.
Sorrento secures Brazil clearance to start Phase IIa long Covid trial
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
Resverlogix starts Phase IIb oral Covid-19 drug trial
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
HDT Bio dose first subjects in Phase I Covid-19 vaccine trial
The trial will enrol 90 subjects to assess the safety, tolerability, and immunogenicity of three dose levels of the vaccine.
Eiger obtains DSMB advice to continue Phase III Covid-19 therapy trial
The trial plans to enrol approximately 1,600 Covid-19 patients, with recruitment progressing at 12 trial centres in Brazil.